Product Information
ALPHAGAN P 0.1% DROPS is a brand product labeled by Allergan, Inc., priced at $37.2541 per ML under NDC 00023932115. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 19, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the brimonidine tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/mL
Manufacturer
Allergan, Inc.NDC
00023932115
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA021770FDA Approved
8/19/2005
TE Code
AB
On Market Since
1/25/2006
Pharmacological Classes
Price Statistics
The NADAC for ALPHAGAN P 0.1% DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 124.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.2541 per ML |
|---|---|
| All-time high | $37.4100 (Apr 10, 2024) |
| All-time low | $16.5725 (Nov 28, 2013) |
| 52-week high | $37.3659 |
| 52-week low | $37.2436 |
| Median price | $32.2028 |
| Average price | $30.3224 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
brimonidine tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALPHAGAN P 0.1% DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ALPHAGAN P 0.1% DROPS, manufactured by Allergan, Inc., is $37.2541 per ML (NDC 00023932115), effective Sep 30, 2026.
How has the price of ALPHAGAN P 0.1% DROPS changed over time?
Over the history we have for it, the NADAC for ALPHAGAN P 0.1% DROPS has risen 124.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALPHAGAN P 0.1% DROPS?
Since Nov 28, 2013, the NADAC for ALPHAGAN P 0.1% DROPS has ranged from a low of $16.5725 (Nov 28, 2013) to a high of $37.4100 (Apr 10, 2024), with a median of $32.2028 per ML.
Are there cheaper alternatives to ALPHAGAN P 0.1% DROPS?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE TARTRATE 0.1% DROP, is $6.5539 per ML — about 82% below ALPHAGAN P 0.1% DROPS.
Who manufactures ALPHAGAN P 0.1% DROPS?
ALPHAGAN P 0.1% DROPS (NDC 00023932115) is labeled by Allergan, Inc., and CMS classifies it as a brand product.